Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D.
about
Age-dependent parathormone levels and different CKD-MBD treatment practices of dialysis patients in Hungary--results from a nationwide clinical auditUse of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients.Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism.Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns.Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D studyPTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidismAssociation of bone mineral density with biochemical markers of bone turnover in hemodialysis children.Diseases of the parathyroid gland in chronic kidney disease.Clinical features of CKD-MBD in Japan: cohort studies and registry.The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study.Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan.A Japanese approach for CKD-MBDClinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level.Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.Higher dialysate calcium concentration is associated with incident myocardial infarction among diabetic patients with low bone turnover: a longitudinal study.Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism
P2860
Q34831607-A94CA7FE-2246-40EC-91B4-221F459ADADCQ35391160-FEF43B8C-3465-40C6-80D8-BC963EE2EACCQ35658726-8BACEFE3-5485-46D4-89B9-7CAAE34CB11DQ35983513-25E8D17D-2084-4B00-9EB7-93FBD472DF74Q36199558-15237A83-1404-4B4B-997B-F26D2BB95809Q36793098-ED52C614-9DF5-474C-B6C1-FF7E51FF3944Q37291922-DEBA8787-7F52-44A0-9E78-71D9745FFDB1Q37912038-37F83209-C914-4935-9738-63CC4792ECA8Q38784139-D0BE8E4C-657D-448B-A79A-82F04F11D8D1Q40200123-B1BF77C5-D087-4984-B182-A650BAE23674Q42727650-87F49B77-5559-45B0-B42E-46777ADBB77FQ42727652-5273DFC9-24FC-46FF-984C-F1A6CD80915AQ43427754-BDBBA517-9DE6-4D13-927D-262718414FF2Q44250442-0AF6F839-33EB-4268-9CB0-460E1004EEC9Q50789348-D3B666D1-0195-4E26-9BCC-3C10EEA0EA96Q55528210-63FC7323-1EB5-44D1-A15B-E4160FDDC6A6Q57218945-AE67AA5C-F79A-462C-9BCA-59D36C80A636
P2860
Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Mineral metabolism management ...... baseline data from the MBD-5D.
@ast
Mineral metabolism management ...... baseline data from the MBD-5D.
@en
type
label
Mineral metabolism management ...... baseline data from the MBD-5D.
@ast
Mineral metabolism management ...... baseline data from the MBD-5D.
@en
prefLabel
Mineral metabolism management ...... baseline data from the MBD-5D.
@ast
Mineral metabolism management ...... baseline data from the MBD-5D.
@en
P2093
P2860
P356
P1476
Mineral metabolism management ...... baseline data from the MBD-5D.
@en
P2093
Kiyoshi Kurokawa
MBD-5D Study Group
Shunichi Fukuhara
Tadao Akizawa
Yoshihiro Onishi
P2860
P304
P356
10.1159/000327654
P577
2011-04-21T00:00:00Z